RM50m Fund, IPO End Game: Sivapalan's Bet on Profitable Malaysian Startups

AI Summary

Veteran investor Dr Sivapalan Vivekarajah, active in Malaysia's startup scene since 1999, has launched Cypress Drive Ventures — a RM50 million fund that will only back startups that are already profitable, with initial public offerings (IPOs), not quick acquisitions, as the intended exit. The strategy is a direct rejection of the burn-cash-and-grow-fast venture model, replacing it with patient capital, stronger founders, and companies built to last as Malaysian businesses. For Malaysian SME owners and AI builders, the signal is blunt: the local funding market is starting to pay for profit, not just growth stories.

Key Takeaways

• Cypress Drive Ventures is a RM50m fund backing startups that are already profitable — an unusual filter in a market where most venture money has chased growth metrics.
• The intended exit is an IPO, not a "quick flip" to an acquirer — which changes how founders must run the company from day one.
• Dr Sivapalan has been in Malaysia's startup trenches for 27 years, since 1999, and Digital News Asia describes him as arguably the most positive figure in the local ecosystem — making his pivot to a discipline-first thesis a meaningful signal.
• The fund's stated ingredients are stronger founders, profitability, and patient capital, aimed at building enduring Malaysian companies.
• For AI startups Malaysia-wide, the bar has shifted: revenue and margins now open doors that user counts and downloads used to.

What Happened

Dr Sivapalan Vivekarajah has launched Cypress Drive Ventures, a new RM50 million fund with a thesis that cuts against how Malaysian venture capital has mostly operated. According to Digital News Asia, the fund will back profitable startups and treat the IPO — the company listing its shares on a stock exchange — as the end game, rather than building a company to sell quickly to a larger buyer.

The man behind it is not a newcomer testing a theory. Dr Sivapalan has been involved in Malaysia's startup scene since 1999, giving him 27 years of direct experience across boom cycles, corrections, and everything in between. DNA goes as far as calling him arguably the most positive person in the ecosystem, a reputation earned over nearly three decades of showing up for local founders.

The fund's stated bet has three parts: stronger founders, profitability, and patient capital. In plain terms, that means finding founders who can run real businesses with positive cash flow, then giving them money without pressuring them into a fast sale. The goal, as DNA frames it, is to build enduring Malaysian startups — companies that stay Malaysian, list on an exchange, and keep compounding.

That last point matters more than it first appears. Most venture funds in Southeast Asia operate on a fixed fund life, typically pushing portfolio companies toward an exit — a sale or listing — within five to seven years. An explicit IPO-first mandate, backed by "patient" capital, tells founders the clock ticks slower here.

Why It Matters

For roughly fifteen years, the dominant venture playbook — imported from Silicon Valley — has been: raise big, spend big on growth, worry about profit later, and exit via acquisition